OCE.JPG

WHAT: The FDA’s Oncology Center of Excellence (OCE) formed 2 months ago

WHY: To leverage combined expertise in drugs, biologics, and devices to expedite development of oncology-related medical products and support an integrated review

WHO: Richard Pazdur, M.D.Acting Director

HOW: Oncology meetings hosted by FDA and stakeholders

LEARN

Published by Drug & Device Advisory Group


One thought on “FDA Oncology Center of Excellence”

  1. Pingback: FDA News: Oncology Center of Excellence, Drug Pricing, Alzheimer’s Disease – Drug and Device Digest

Leave a Reply


Fill in your details below or click an icon to log in:

Gravatar

WordPress.com Logo



You are commenting using your WordPress.com account.
( Log Out / 
Change )

Google photo



You are commenting using your Google account.
( Log Out / 
Change )

Twitter picture



You are commenting using your Twitter account.
( Log Out / 
Change )

Facebook photo



You are commenting using your Facebook account.
( Log Out / 
Change )

Cancel

Connecting to %s